L565-1393 Screening compound: N-[(3-fluorophenyl)methyl]-3-methyl-1-(1-methyl-1H-pyrazole-5-carbonyl)piperidine-3-carboxamide

L565-1393 Screening compound: N-[(3-fluorophenyl)methyl]-3-methyl-1-(1-methyl-1H-pyrazole-5-carbonyl)piperidine-3-carboxamide
L565-1393 Screening compound: N-[(3-fluorophenyl)methyl]-3-methyl-1-(1-methyl-1H-pyrazole-5-carbonyl)piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L565-1393
N-[(3-fluorophenyl)methyl]-3-methyl-1-(1-methyl-1H-pyrazole-5-carbonyl)piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L565-1393

Molecular Formula

C19H23FN4O2 (C19 H23 FN4 O2)

Compound Name

N-[(3-fluorophenyl)methyl]-3-methyl-1-(1-methyl-1H-pyrazole-5-carbonyl)piperidine-3-carboxamide

IUPAC name

N-[(3-fluorophenyl)methyl]-3-methyl-1-(1-methyl-1H-pyrazole-5-carbonyl)piperidine-3-carboxamide

SMILES

CC(CCC1)(CN1C(c1ccnn1C)=O)C(NCc1cccc(F)c1)=O

InChI

InChI=1S/C19H23FN4O2/c1-19(18(26)21-12-14-5-3-6-15(20)11-14)8-4-10-24(13-19)17(25)16-7-9-22-23(16)2/h3,5-7,9,11H,4,8,10,12-13H2,1-2H3,(H,21,26)/t19-/m0/s1

InChI Key

GPPGACHXSYRVKD-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27462811

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

358.42

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.515

Distribution Coefficient, logD

1.515

Water Solubility, LogSw

-2.08

Polar Surface Area

54.884

Acid Dissociation Constant (pKa)

12.24

Base Dissociation Constant (pKb)

1.56

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.10

L565-1393 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Immunological Library (6760 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
Targets:
  • Others

References: we are preparing a list of scientific research reports with L565-1393 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L565-1393?
Check Price and Availability of L565-1393, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L565-1393 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L565-1393
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L565-1393
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L565-1393 available by request